We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » J&J’s Single-Dose Vaccine Nears FDA Authorization, but Appears Weakened by South African Strain
J&J’s Single-Dose Vaccine Nears FDA Authorization, but Appears Weakened by South African Strain
Johnson & Johnson is expected to file for Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine this week, but the much-needed shot has shown to be significantly less effective than its Pfizer/BioNTech and Moderna counterparts and looks to have problems tackling the virus’ highly contagious South African variant.